Icarus Medical Raises $7.2 Million Series A to Expand Orthopedic Bracing Technology

June 18, 2026
Icarus Medical, based in Charlottesville, Virginia, has closed a $7.2 million Series A funding round to accelerate commercialization and development of its orthopedic bracing technology.

Icarus Medical has closed a $7.2 million Series A funding round, announced in a press release. The company, based in Charlottesville, Virginia, originally targeted $5 million but exceeded that amount due to strong investor interest.

The financing will support expanded commercialization across the United States, continued product development, manufacturing growth, clinical validation of current devices, and team expansion. The company aims to strengthen its national presence in the orthopedic technology market.

Investors in the round include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors. These partners will also provide strategic expertise in healthcare operations and commercialization.

Founded in Charlottesville, Icarus Medical develops orthopedic bracing technologies that combine biomechanics, additive manufacturing, and patient-focused design to help users maintain mobility while reducing pain and improving function.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

06/18
Vali Health Raises $6 Million to Build AI Infrastructure for Home Care
06/18
DeepL Expands to San Francisco and Integrates Mixhalo Team and Technology
06/18
KLIPY Raises $3.8 Million and Joins Google AI Futures Fund
06/18
Lyntris Acquires Novium to Strengthen Satellite Motion Systems
06/18
Ploy Raises $27 Million and Launches AI Marketing Platform

More from: Life Sciences

06/18
Vali Health Raises $6 Million to Build AI Infrastructure for Home Care
06/18
Lunai Bioworks CEO Updates Shareholders on Defense Contracts, AI Biodefense, and Legal Action
06/18
LG AI Research and D&D Pharmatech Partner on AI-Driven Oral Peptide Drugs
06/18
HistoIndex AI Analysis Confirms Fibrosis Improvement in D&D Pharmatech Phase 2 MASH Trial
06/18
Coreline Soft and Mint Medical Partner on AI Lung Cancer Screening Integration

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like